(Q39765671)

14 September 2017

TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compounds (English)

1 reference

14 September 2017

0 references

1 reference

6

Naoki Yamamoto

1 reference

14 September 2017

5

Tetsutaro Sata

1 reference

14 September 2017

Shiori Haga

1

1 reference

14 September 2017

Noriyo Nagata

2

1 reference

14 September 2017

Tadashi Okamura

3

1 reference

14 September 2017

Norio Yamamoto

4

1 reference

14 September 2017

Takehiko Sasazuki

7

1 reference

14 September 2017

Yukihito Ishizaka

8

1 reference

14 September 2017

6 December 2009

1 reference

14 September 2017

1 reference

14 September 2017

85

1 reference

14 September 2017

3

1 reference

14 September 2017

551-555

1 reference

Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing

14 September 2017

1 reference

12 December 2020

Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.

1 reference

12 December 2020

Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2).

1 reference

12 December 2020

Specific asparagine-linked glycosylation sites are critical for DC-SIGN- and L-SIGN-mediated severe acute respiratory syndrome coronavirus entry

1 reference

12 December 2020

CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus

1 reference

12 December 2020

Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry

1 reference

12 December 2020

Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice

1 reference

12 December 2020

Modulation of TNF-alpha-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-alpha production and facilitates viral entry

1 reference

12 December 2020

Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors

1 reference

12 December 2020

Severe acute respiratory syndrome coronavirus entry as a target of antiviral therapies

1 reference

12 December 2020

Identifying epitopes responsible for neutralizing antibody and DC-SIGN binding on the spike glycoprotein of the severe acute respiratory syndrome coronavirus

1 reference

12 December 2020

Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association

1 reference

12 December 2020

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

1 reference

12 December 2020

A novel coronavirus associated with severe acute respiratory syndrome

1 reference

12 December 2020

A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2

1 reference

12 December 2020

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

1 reference

12 December 2020

The ADAMs family of metalloproteases: multidomain proteins with multiple functions

1 reference

12 December 2020

A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury

1 reference

12 December 2020

A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase

1 reference

12 December 2020

10.1016/J.ANTIVIRAL.2009.12.001

Identifiers

DOI

1 reference

14 September 2017

1 reference